Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137

Site search

Correspondence address
310 Mira Street, Stavropol, Russia, 355017

+7 8652 352524; +7 8652 353229.

+7 8652 352524.


Methidical approaches to bioassay of phenolic hydroxylenes contain substances

[Experimental medicine]
Alexander Khokhlov; Ilya Yaichkov; Yuriy Dzhurko; Leonid Shitov;

This article describes method of development approaches for bioassay of substances containing stable and unstable phenolic hydroxyls using methyldopa and mycophenolic acid for example


1. On the Approval of the Rules for Conducting Bioequivalence Studies of Medicinal Products within the Eurasian Economic Union: Decision of the Council of the Eurasian Economic Commission of November 3, 2016. № 85.
2. Tukavkina N. A., ed. Organic chemistry. Book 1: Basic course. Мoscow: Drofa, 2003.
3. Mironov A. N., ed. Manual on expertise of medicines. V. I. Moscow: Grif i K, 2013.
4. Khokhlov A. L., Shitov L. N., Dzhurko Y. A. [et al.] Quantitative determination of mycophenolic acid in human plasma by liquid chromatography – tandem mass spectrometry. Pharm. Chem. J. 2017; 51(6): 58-61.
5. Benoit-Biancamano M.-O., Caron P., Levesque E. [et al.] Sensitive high-performance liquid chromatography–tandem massspectrometry method for quantitative analysis of mycophenolic acid and its glucuronide metabolites in human plasma and urine. J. Chromatogr B. 2007; 858: 159–167. doi:10.1016/j.jchromb.2007.08.023
6. Brandhorst G., Streit F., Goetze S. [et al.] Quantification by Liquid Chromatography Tandem Mass Spectrometry of Mycophenolic Acid and Its Phenol and Acyl Glucuronide Metabolites. Clin. Chem. 2006;52(10):1962-1964. doi: 10.1373/clinchem.2006.074336
7. Buchwald A., Winkler K., Epting T. [et al.] Validation of an LC–MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA. BMC Clin. Pharm. 2012;12:1-11. doi: 10.1186/1472-6904-12-2
8. Delavenne X., Juthier L., Pons B. [et al.] UPLC–MS/MS method for quantification of mycophenolic acid and metabolites in human plasma: Application to pharmacokinetic study. Clin. Chim. Act. 2011;412:59-65. doi:10.1016/j.cca.2010.09.041
9. Elbarty F. A., Shoke A. S. Liquid chromatographic determination of mycophenolic acid and its metabolites in human kidney transplant plasma: Pharmacokinetic application. J. Chromatogr. B. 2007;859:276-281. doi:10.1016/j.jchromb.2007.09.036
10. Guideline on validation of bioanalytical methods (draft): European Medicines Agency, Committee for medicinal products for human use, 2013.
11. Heinig K., Bucheli F., Hartenbach R. [et al.] Determination of mycophenolic acid and its phenyl glucuronide in human plasma, ultrafiltrate, blood, DBS and dried plasma spots. Bioanal. 2010;8(2):1423-1435. doi: 10.4155/bio.10.99
12. Li W., Zhang J., Tse F. L. S. Handbook of LC-MS Bioanalysis. New Jersey: Jonh Wiley and Sons, 2013.
13. Maddela R., Pilli N. R., Maddela S. A novel and Rapid LC–MS/MS assay for the Determination of Mycophenolate and Mycophenolic Acid in Human Plasma. J. Young Pharm. 2017; 9 (1):107-114. doi: 10.5530/jyp.2017.9.20
14. Oliveira C. H., Barrientos-Astigarraga R. E., Sucupira M. [et al.] Quantification of methyldopa in human plasma by high-performance liquid chromatography–electrospray tandem mass spectrometry. Application to a bioequivalence study. J. Chromatogr. B. 2002;768(2): 341-348. doi: 10.1016/S1570-0232(01)00612-2
15. Rebollo N., Calvo M. V., Martin-Saurez A. [et al.] Modification of the EMIT immunoassay for the measurement of unbound mycophenolic acid in plasma. Clin. Biochem. 2011;44:260-263. doi: 10.1016/j.clinbiochem.2010.09.025
16. Róna K., Ary K., Renczes G. [et al.] Comparative Bioavailability of Alpha-Methyldopa normal and film tablet formulations after single oral administration in healthy volunteers. Eur. J. Drug Metab. and Pharmacok. 2001;26(1-2):25-30.
17. Valizadeh H., Nemati M., Hallaj-Nezhadi S. [et al.] Single dose bioequivalence study of a-methyldopa tablet formulations using a modified HPLC method. Arzn. 2010;60(10):607-611. doi: 10.1055/s-0031-1296333
18. Van de Merbel N. C., Hendriks G., Imbos R. [et al.] Quantitative determination of free and total dopamine in human plasma by LC-MS/MS: the importance of sample preparation. Bioanal. 2011;17(3):1949-1961. doi: 10.4155/bio.11.170
19. Vlase L., Mihu D., Popa D.-S. Determination of methyldopa in human plasma by LC/MS-MS for therapeutic drug monitoring. Stud. Univ. Babes-Bolyai Chem. 2013;58(1):31-41.
20. Upadhuaya V., Trivedy V., Shah G. [et al.] Determination of mycophenolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry. J. Pharm. Anal. 2014;4(3):205-216. doi: 10.1016/j.jpha.2013.06.001
21. Wang L., Qiang W., Li Y. [et al.] A novel freeze-dried storage and preparation method for the determination of mycophenolic acid in plasma by high-performance liquid chromatography. Biomed. Chromatogr. 2017;31(5):3-27. doi:10.1002/bmc.3958
22. Wiesen M. H. J., Farowski F., Feldkötter M. [et al.] Liquid chromatography–tandem mass spectrometry method for the quantification of mycophenolic acid and its phenolic glucuronide in saliva and plasma using a standardized saliva collection device. J. Chromatogr. A. 2012;1241:52-59. doi: 10.1016/j.chroma.2012.04.008

Keywords: phenolic hydroxyls, bioassay, mycophenolic acid, methyldopa, stabilization

Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy